89bio Inc (ETNB)
8.095
-0.66
(-7.49%)
USD |
NASDAQ |
Nov 15, 10:51
89bio Cash and Short Term Investments (Quarterly): 423.77M for Sept. 30, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 423.77M |
| June 30, 2024 | 531.38M |
| March 31, 2024 | 562.29M |
| December 31, 2023 | 578.87M |
| September 30, 2023 | 448.30M |
| June 30, 2023 | 478.00M |
| March 31, 2023 | 480.88M |
| December 31, 2022 | 188.16M |
| September 30, 2022 | 193.34M |
| June 30, 2022 | 139.32M |
| March 31, 2022 | 126.09M |
| December 31, 2021 | 150.72M |
| Date | Value |
|---|---|
| September 30, 2021 | 157.33M |
| June 30, 2021 | 170.96M |
| March 31, 2021 | 189.62M |
| December 31, 2020 | 204.63M |
| September 30, 2020 | 219.15M |
| June 30, 2020 | 73.90M |
| March 31, 2020 | 85.53M |
| December 31, 2019 | 93.34M |
| September 30, 2019 | 16.19M |
| June 30, 2019 | 21.92M |
| December 31, 2018 | 11.23M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
73.90M
Minimum
Jun 2020
578.87M
Maximum
Dec 2023
274.78M
Average
191.48M
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Madrigal Pharmaceuticals Inc | 998.63M |
| Eli Lilly and Co | 3.518B |
| Viking Therapeutics Inc | 930.44M |
| Akero Therapeutics Inc | 717.25M |
| NovaBay Pharmaceuticals Inc | 0.776M |